DiaMedica Therapeutics Stock (NASDAQ: DMAC) stock price, news, charts, stock research, profile.
You can purchase shares of DiaMedica Therapeutics (NASDAQ:DMAC) through any online brokerage.
There are no as such competitors for DiaMedica Therapeutics.
DiaMedica Therapeutics has a consensus price target of $7.25.
The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $4 last updated November 21, 2024 at 9:14 AM EST.
There are no upcoming dividends for DiaMedica Therapeutics.
DiaMedica Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for DiaMedica Therapeutics.
DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.